According to Inozyme Pharma's latest financial reports the company's current earnings (TTM) are -S$0.11 B. In 2023 the company made an earning of -S$84.62 M an increase over its 2022 earnings that were of -S$89.46 M.The earnings displayed on this page is the company's Pretax Income.